metricas
covid
Buscar en
Annals of Hepatology
Toda la web
Inicio Annals of Hepatology P-27 DESCRIPTIVE STUDY ON PATIENTS WITH HEPATOCARCINOMA IN A PUBLIC HOSPITAL 201...
Información de la revista
Vol. 29. Núm. S1.
Abstracts of the 2023 Annual Meeting of the ALEH
(febrero 2024)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 29. Núm. S1.
Abstracts of the 2023 Annual Meeting of the ALEH
(febrero 2024)
Acceso a texto completo
P-27 DESCRIPTIVE STUDY ON PATIENTS WITH HEPATOCARCINOMA IN A PUBLIC HOSPITAL 2018-2023
Visitas
138
Paula Andrea Huerta1, Matías Alberto Salazar1, Joaquín Jensen1,2, Alexandra Ginesta2
1 Internal Medicine, Hospital Padre Hurtado, Santiago, Chile
2 Digestive Surgery, Hospital Padre Hurtado - Clínica Alemana, Santiago, Chile
Este artículo ha recibido
Información del artículo
Suplemento especial
Este artículo forma parte de:
Vol. 29. Núm S1

Abstracts of the 2023 Annual Meeting of the ALEH

Más datos
Introduction and Objectives

Hepatocellular carcinoma (HCC) is the most frequent malignant tumor of the liver. Patients with chronic liver damage (CLD) are at increased risk of HCC. Periodic screening seeks to increase survival. In Chile, information about patients with HCC is still scarce. This study aimed to describe clinical and epidemiological characteristics of patients with HCC from a public hospital in Santiago-Chile, during 2018-2023.

Materials and Methods

retrospective descriptive study on patients with HCC presented to the oncology committee, based on the hospital system's database. Analysis of variables age, sex, presence and characteristics of CLD, screening, tumor characteristics, treatment and survival, and statistical associations with the SPSS program.

Results

114 patients were registered (56% men), with a mean age of 69 years. At diagnosis: 90% had CLD, 33% were diagnosed by screening, 51% with Child-Pugh A score, 52% had only one focal lesion, and the mean tumor size was 6.8 cm. More than 90% were not candidates for transplantation due to the Milan criteria and/or functionality (ECOG). 2 patients were transplanted; 54% were only eligible for palliative care. 64% had died at the time of the study, with an average survival of 179 days (range 1 – 886 days); 68% died within 6 months. There was a higher survival in Child-Pugh A versus C patients, and in screened versus non-screened patients (mean 278 vs. 150 days, respectively), both statistically significant (p<0,05).

Conclusions

The diagnosis of HCC continues to be late, with a low percentage of diagnosis through screening in patients with CLD, decreasing their survival, and with low access to curative therapy and liver transplantation. These data will be used to design a prospective model in order to improve the diagnosis and management of these patients.

El Texto completo está disponible en PDF
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos